MEDICATION OVERUSE HEADACHE, WHY IT HAPPENED?
Abstract
Medication Overuse Headache (MOH) is a secondary headache -- worsening condition of preexisting headache (usually primary hedache). MOH occurs due to medication overuse to relief the pain or to treat the headache attack. The etiology of MOH is the excessive use of single and combined analgesics, nonsteroidal anti-inflammatory drugs, caffeine, opioids, ergotamine, triptans and barbiturates. MOH is a chronic headache which need to recognize early. Diagnosis, accurate therapy, and management of comorbidities must be done to improve patient’s productivity and quality of life.
Keywords
Full Text:
PDFReferences
Alstadhaug KB, Ofte HK, Kristoffersen ES. Preventing and treating medication overuse headache. Clinical Update. 2017. e612.
Boes CJ, Capobianco DJ. Chronic migraine and medication-overuse headache through the ages. Cephalalgia 2005;25:378–90.
Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 2013;33:629–808.
Diener HC, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol 2004;3:475–83.
Evers S, Jensen R. Treatment of medication overuse headache—guideline of the EFNS headache panel. Eur J Neurol 2011;18:1115–21.
Hagen K, Linde M, Steiner TJ, Stovner LJ, Zwart JA. Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord- Trondelag Health Studies. PAIN 2012;153:56–61.
Jonsson P, Hedenrud T, Linde M. Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia 2011;31: 1015–22.
Lanteri-Minet M, Duru G, Mudge M, Cottrell S. Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review. Cephalalgia 2011;31:837–50.
Westergaard ML, Glumer C, Hansen EH, Jensen RH. Prevalence of chronic headache with and without medication overuse: associations with socioeconomic position and physical and mental health status. PAIN 2014;155:2005–13.
Westergaard ML, Hansen EH, Glumer C, Olesen J, Jensen RH. Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review. Cephalalgia 2014;34:409–25.
Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC. Features of medication overuse headache following overuse of different acute headache drugs. Neurology 2002;59:1011–4.
Driel MV, Anderson E, McGuire T, Stark r. Medication overuse headache: strategies for prevention and treatment using a multidisciplinary approach. Hong Kong Med J 2018;24:617–22
Khu JV, Siow HC, Ho KH. Headache diagnosis, management and morbidity in the Singapore primary care setting: findings from a general practice survey. Singapore Med J 2008;49:774-9.
Vandenbussche N, Laterza D, Lisicki M, Lloyd J, Lupi C, Tischler H, Toom K, Vandervorst F, Quintana S, Paemeleire K, Katsarava Z. Medication-overuse headache: a widely recognized entity amidst ongoing debate. The Journal of Headache and Pain (2018) 19:50
Bigal ME, Lipton RB (2008) Excessive acute migraine medication use and migraine progression. Neurology 71:1821–1828.
Thorlund K, Sun-Edelstein C, Druyts E et al (2016) Risk of medication overuse headache across classes of treatments for acute migraine. J Headache Pain 17(1):107
Paemeleire K, Crevits L, Goadsby PJ, Kaube H. Practical management of medication-overuse headache. Acta neurol. belg., 2006, 106, 43-51
Diener H. C., Limmroth V. Medication-ove. ruse headache : a worldwide problem. Lancet Neurol., 2004, 3 (8) : 475-483.
Young W. B. Medication Overuse Headache. Curr. Treat. Options Neurol., 2001, 3 (2) : 181-188.
Fischer MA, Jan A. Medication-overuse Headache (MOH) [Updated 2019 Nov 14]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538150/
Belanger, S., Ma, W., Chabot, J. and Quirion, R. (2002) expression of calcitonin gene-related peptide, substance p and protein kinase c in cultured dorsal root ganglion neurons following chronic exposure to mu, delta and kappa opiates. Neuroscience 115: 441–453.
De Felice, M., Ossipov, M., Wang, R., Lai, J., Chichorro, J., Meng, I. et al. (2010) Triptan-induced latent sensitization: a possible basis for medication overuse headache. Ann Neurol 67: 325–337.
DOI: http://dx.doi.org/10.32883/hcj.v5i1.658
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 4.0 International License.
HUMAN CARE JOURNAL
Published by Universitas Fort De Kock, Bukittinggi, Indonesia
© Human Care Journal e-ISSN : 2528-665X P-ISSN : 2685-5798